10/08/1996 - EIU Homecoming Features Movie Theme.pdf

During the high cycle fatigue of aluminium alloys, an energy dissipation occurs. This dissipation is hard to be estimated because of the high diffusivity of such alloys and the importance of the thermoelasticity effects in comparison with others standard metallic materials (e.g., steels). Nevertheless the study of the energy balance gives valuable information about the nature of deformation mechanisms facilitating the construction of constitutive models associated with the microplasticity and damage of the aluminium alloy. In this work, the different energies involved in the energy balance were deduced from two complementary imaging techniques. The dissipation and thermoelastic sources were derived from an infrared thermography system, while the deformation energy was estimated from a digital image correlation system. Three tests with various loading blocks were carried out and a comparison between deformation and dissipation energies was systematically performed. (C) 2009 Elsevier Ltd. All rights reserved

Photoresponsive multilayer films by assembling cationic amphiphilic cyclodextrins and anionic porphyrins at the air/water interface

Densely packed hybrid monolayers of amphiphilic cyclodextrins incorporating hydrophilic porphyrins are formed at the air/water interface through electrostatic interaction and can be transferred onto quartz substrates by Langmuir–Scha¨fer deposition. The resulting multilayers exhibit a good response to light excitation as proven by fluorescence emission, triplet– triplet absorption and singlet oxygen photogeneration

Proline enantiomers discrimination by (L)-prolinated porphyrin derivative Langmuir-Schaefer films: proof of concept for chiral sensing applications

A porphyrin derivative functionalized with the L-enantiomer of proline amino acid was characterized at the air-pure water interface of the Langmuir trough. The porphyrin derivative was dissolved in dichloromethane solution, spread at the air-subphase interface and investigated by acquiring the surface pressure vs. area per molecule Langmuir curves. It is worth observing that the behavior of the molecules of the porphyrin derivative floating film was substantially influenced by the presence of L-proline amino acid dissolved in the subphase (10(-5) M); on the contrary, the physical chemical features of the floating molecules were only slightly influenced by the D-proline dissolved in the subphase. Such an interesting chirality-driven selection was preserved when the floating film was transferred onto solid supports by means of the Langmuir-Schaefer method, but it did not emerge when a spin-coating technique was used for the layering of the tetrapyrrolic derivatives. The obtained results represent proof of concept for the realization of active molecular layers for chiral discrimination: porphyrin derivatives, due to their intriguing spectroscopic and supramolecular properties, can be functionalized with the chiral molecule that should be detected. Moreover, the results emphasize the crucial role of the deposition technique on the features of the sensing layers

Proline Enantiomers Discrimination by (L)-Prolinated Porphyrin Derivative Langmuir–Schaefer Films: Proof of Concept for Chiral Sensing Applications

A porphyrin derivative functionalized with the L-enantiomer of proline amino acid was characterized at the air–pure water interface of the Langmuir trough. The porphyrin derivative was dissolved in dichloromethane solution, spread at the air–subphase interface and investigated by acquiring the surface pressure vs. area per molecule Langmuir curves. It is worth observing that the behavior of the molecules of the porphyrin derivative floating film was substantially influenced by the presence of L-proline amino acid dissolved in the subphase (10−5 M); on the contrary, the physical chemical features of the floating molecules were only slightly influenced by the D-proline dissolved in the subphase. Such an interesting chirality-driven selection was preserved when the floating film was transferred onto solid supports by means of the Langmuir–Schaefer method, but it did not emerge when a spin-coating technique was used for the layering of the tetrapyrrolic derivatives. The obtained results represent proof of concept for the realization of active molecular layers for chiral discrimination: porphyrin derivatives, due to their intriguing spectroscopic and supramolecular properties, can be functionalized with the chiral molecule that should be detected. Moreover, the results emphasize the crucial role of the deposition technique on the features of the sensing layers

Robotic Versus Open Kidney Transplantation from Deceased Donors : A Prospective Observational Study

Background: While robot-assisted kidney transplantation (RAKT) from living donors has been shown to achieve favourable outcomes, there is a lack of evidence on the safety and efficacy of RAKT as compared with the gold standard open kidney transplantation (OKT) in the setting of deceased donors, who represent the source of most grafts worldwide. Objective: To compare the intraoperative, perioperative, and midterm outcomes of RAKT versus OKT from donors after brain death (DBDs). Design, setting, and participants: Data from consecutive patients undergoing RAKT or OKT from DBDs at a single academic centre between October 2017 and December 2020 were prospectively collected. Intervention: RAKT or OKT. Outcome measurements and statistical analysis: The primary outcomes were intraoperative adverse events, postoperative surgical complications, delayed graft function (DGF), and midterm functional outcomes. A multivariable logistic regression analysis assessed the independent predictors of DGF, trifecta, and suboptimal graft function (estimated glomerular filtration rate [eGFR] <45 ml/min/1.73 m) at the last follow-up. Results and limitations: Overall, 138 patients were included (117 [84.7%] OKTs and 21 [15.3%] RAKTs). The yearly proportion of RAKT ranged between 10% and 18% during the study period. The OKT and RAKT cohorts were comparable regarding all graft-related characteristics, while they differed regarding a few donor- and recipient-related factors. The median second warm ischaemic time, ureterovesical anastomosis time, postoperative complication rate, and eGFR trajectories did not differ significantly between the groups. A higher proportion of patients undergoing OKT experienced DGF; yet, at a median follow-up of 31 mo (interquartile range 19-44), there was no difference between the groups regarding the dialysis-free and overall survival. At the multivariable analysis, donor- and/or recipient-related factors, but not the surgical approach, were independent predictors of DGF, trifecta, and suboptimal graft function at the last follow-up. The study is limited by its nonrandomised nature and the small sample size. Conclusions: Our study provides preliminary evidence supporting the noninferiority of RAKT from DBDs as compared with the gold standard OKT in carefully selected recipients. Patient summary: Kidney transplantation using kidneys from deceased donors is still being performed with an open surgical approach in most transplant centres worldwide. In fact, no study has compared the outcomes of open and minimally invasive (robotic) kidney transplantation from deceased donors. In this study, we evaluated whether robotic kidney transplantation using grafts from deceased donors was not inferior to open kidney transplantation regarding the intraoperative, postoperative, and midterm functional outcomes. We found that, in experienced hands and provided that there was a time-efficient organisation of the transplantation pathway, robotic kidney transplantation from deceased donors was feasible and achieved noninferior outcomes as compared with open kidney transplantation

Disease activity and damage in juvenile idiopathic arthritis: Methotrexate era versus biologic era

Objective: To compare the long-term disease state, in terms of activity and damage, of children with juvenile idiopathic arthritis (JIA) who had their disease onset in methotrexate (MTX) or biologic eras. Methods: Patients were included in MTX or biologic era cohort depending on whether their disease presentation occurred before or after January 2000. All patients had disease duration 65 5 years and underwent a prospective cross-sectional assessment, which included measurement of disease activity and damage. Inactive disease (ID) and low disease activity (LDA) states were defined according to Wallace, JADAS10, and cJADAS10 criteria. Articular and extraarticular damage was assessed with the Juvenile Arthritis Damage Index (JADI). Results: MTX and biologic era cohorts included 239 and 269 patients, respectively. Patients were divided in the "functional phenotypes" of oligoarthritis and polyarthritis. At cross-sectional visit, patients in the biologic era cohort with either oligoarthritis or polyarthritis had consistently higher frequencies of ID and LDA by all criteria. The measurement of disease damage at cross-sectional visit revealed that the frequency of impairment of &gt; 1 JADI-Articular items was higher in MTX than in biologic era cohort (17.6% versus 11% in oligoarthritis and 52.6% versus 21.8% in polyarthritis). Likewise, frequency of involvement of &gt; 1 JADI-Extraarticular items was higher in the MTX than in the biologic era cohort (26.5% versus 16.2% in oligoarthritis and 31.4% versus 13.5% in polyarthritis). Conclusion: Our study provides evidence of the remarkable outcome improvement obtained with the recent therapeutic advance in JIA

Le immunoglobuline per via endovenosa nel trattamento delle neuropatie infantili

Agli inizi degli anni ’80, l’avvento dei preparati di immunoglobuline per via endovenosa (IVIG) nella la terapia sostitutiva delle ipo-agammaglobulinemie, ha radicalmente cambiato la prognosi dei pazienti con immunodeficienze umorali 1. Fino ad allora infatti erano utilizzabili solo preparati per via intramuscolare, con importanti limitazioni legate ai volumi di liquido iniettabili per questa via e la sostituzione degli anticorpi carenti era perciò poco soddisfacente. La disponibilità delle IVIG (quindi la possibilità di somministrare grandi volumi = quantità di IgG) non solo ha consentito la completa sostituzione dei difetti anticorpali, ma ha anche aperto la strada ad altri impieghi sfruttandone le attività immunomodulanti e antinfiammatorie prima sconosciute e rivelatesi in modo del tutto occasionale. Fu Imbach che casualmente osservò in un paziente con difetto anticorpale e piastrinopenia non solo la normalizzazione delle IgG, ma anche del numero di piastrine, in corso di terapia con IVIG e intraprese il primo studio con IVIG in pazienti con porpora trombocitopenia idiopatica, dimostrandone una eccellente efficacia 2. Da allora i campi applicativi si sono estesi a tutte quelle malattie autoimmuni e infiammatorie per le quali i risultati della terapia classica erano insoddisfacenti e si è focalizzata l’attenzione sui meccanismi attraverso cui le IVIG esercitano la loro azione antinfiammatoria e immunomodulante. Si può dire che ad oggi pressoché tutte le malattie autoimmuni – e le malattie neuromuscolari in particolare per le loro caratteristiche invalidanti ed evolutive – sono state oggetto di tentativi terapeutici con IVIG. I risultati non sono stati sempre incoraggianti e, in considerazione dell’alto costo dei preparati, si è sentita e si sente l’esigenza di porre ordine e di rivedere criticamente tutta la letteratura sull’argomento per dare indicazioni più precise, in accordo ai criteri EBM, sull’impiego di tali preparati. Ormai sono numerose le indicazioni e le consensus redatte sia da Neurologi che da Immunologi; a queste si aggiungono le direttive ufficiali, emanate dagli organi di controllo statali (FDA, WHO, AIFA) che ne approvano le indicazioni per alcune malattie e ne coprono il costo a carico dei sistemi sanitari nazionali. Tuttavia la approvazione riguarda un numero estremamente esiguo di patologie e tuttora le IVIG vengono spesso utilizzate off label

A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis

Background: To investigate the frequency of achievement of inactive disease (ID) in children with juvenile idiopathic arthritis (JIA) treated with methotrexate (MTX) as the sole disease-modifyng antirheumatic (DMARD) therapy and to develop a prediction model for lack of attainment of ID. Methods: The clinical charts of consecutive patients started with MTX as the sole DMARD between 2000 and 2013 were reviewed. Patient follow-up was censored at first episode of ID or, in case ID was not reached, at last follow-up visit or when a biologic DMARD was prescribed. The characteristic at MTX start of patients who achieved or did not achieve ID were compared with univariate and multivariable analyses. Regression coefficients (\u3b2) of variables that entered the best-fitting logistic regression model were converted and summed to obtain a "prediction score" for lack of achievement of ID. Results: A total of 375 patients were included in the study. During MTX administration, 8.8% were given systemic corticosteroids and 44.1% intra-articular corticosteroids. After MTX start, 229 (61%) patients achieved ID after a median of 1.7 years, whereas 146 patients (39%) did not reach ID after a median of 1.2 years. On multivariable analysis, independent correlations with lack of achievement of ID were identified for the disease categories of systemic arthritis, enthesitis-related arthritis (ERA) and polyarthritis and C-reactive protein (CRP) &gt; 1.4 mg/dl. The prediction score ranged from 0 to 3 and its cutoff that discriminated best between patients who achieved or did not achieve ID was &gt; 0.5. The categories of systemic arthritis or ERA, both of which had a score greater than 0.5, were sufficient alone to predict a lower likelihood to reach ID. Polyarthritis and increased CRP, whose score was 0.5, assumed a predictive value only when present in association. Conclusion: A conventional treatment regimen based on MTX as the sole DMARD led to achievement of ID in a sizeable proportion of children with JIA. Our findings help to outline the characteristics of patients who may deserve a synthetic DMARD other than MTX or the introduction of a biologic DMARD from disease outset

Supramolecular amplification of amyloid self-assembly by iodination

Amyloid supramolecular assemblies have found widespread exploitation as ordered nanomaterials in a range of applications from materials science to biotechnology. New strategies are, however, required for understanding and promoting mature fibril formation from simple monomer motifs through easy and scalable processes. Noncovalent interactions are key to forming and holding the amyloid structure together. On the other hand, the halogen bond has never been used purposefully to achieve control over amyloid self-assembly. Here we show that single atom replacement of hydrogen with iodine, a halogen-bond donor, in the human calcitonin-derived amyloidogenic fragment DFNKF results in a super-gelator peptide, which forms a strong and shape-persistent hydrogel at 30-fold lower concentration than the wild-type pentapeptide. This is remarkable for such a modest perturbation in structure. Iodination of aromatic amino acids may thus develop as a general strategy for the design of new hydrogels from unprotected peptides and without using organic solvents